Входя на эту страницу, Вы подтверждаете, что являетесь  медицинским работником.

Status message

Not the entire site translated, but only to "Magazine"

PALIPERIDONE PALMITATE IN THE THERAPY OF THE FIRST EPISODE OF PARANOID SCHIZOPHRENIA (CLINICAL CASE)

Kozlov Ya.S., Antokhin E.Yu., Budza VG, Kryukova EM, Palyayeva SV
Orenburg State Medical University Orenburg Regional Clinical Psychiatric Hospital No. 1

Summary: The publication describes a patient with a newly emerging paranoid syndrome within the framework of paranoid schizophrenia. Treatment with haloperidol led to the deactivation of delusional ideas, but caused the development of extrapyramidal disorders. By stopping the use of antipsychotics, the psychopathological symptoms became more complicated with the development of verbal pseudo-hallucinosis. The transfer from therapy with haloperidol to the injection of paliperidone palmitate resulted in a reduction of psychoactive symptoms, undesirable phenomena of the previous therapy, stabilization of the patient with the first attack of schizophrenia. The use of paliperidone palmitate contributed to the formation of stable remission and the restoration of social functioning.

References: 
  • 1. Budza V.G., Otmahov A.P., Pruss G.B. Otdelenie pervogo psihoticheskogo epizoda – novaya forma organizacii psihiatricheskoj pomoshchi bol'nym shizofreniej // Social'naya i klinicheskaya psihiatriya. – 2005. – T. 15, № 4. – S. 58–62.
  • 2. Gurovich I.Ya., Shmukler A.B., Lyubov E.B. Klinika pervogo psihoticheskogo epizoda (dnevnoj stacionar ili otdelenie s rezhimom dnevnogo stacionara, profilirovannye dlya pomoshchi bol'nym s pervym epizodom shizofrenii): metodich. rekomendacii. – M., 2003.
  • 3. Robinson D., Woerner M.G., Alvir J.M., Bilder R., Goldman R., Geisler S., Koreen A., Sheitman B., Chakos M., Mayerhoff D., Lieberman J.A. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder // Arch Gen Psychiatry. – 1999. – Vol. 56, No. 3. – P. 241–247.
  • 4. Gurovich I.Ya., Lyubov E.B., Storozhakova Ya.A. Vyzdorovlenie pri shizofrenii. Koncepciya “recovery” // Social'naya i klinicheskaya psihiatriya. – 2008. – T. 18, № 2. – S. 7–14.
  • 5. Gurovich I.Ya., Shmukler A.B., Storozhakova Ya.A. Remissiya i lichnostno-social'noe vosstanovlenie (recovery) pri shizofrenii: predlozheniya po 11-mu peresmotru MKB // Social'naya i klinicheskaya psihiatriya. – 2008. – T.18, № 4. – S. 34–39.
  • 6. Budza V.G., Antohin E.Yu., Bomov P.O. Psihiatriya na rubezhe vekov v trudah Orenburgskih psihiatrov. Razdel III: Problemy pervogo psihoticheskogo epizoda shizofrenii i psihosocial'noj terapii // Hrestomatiya. T. II. – Orenburg: Izd-vo OrGMA, 2014. – S. 5–182.
  • 7. Antohin E.Yu., Kozlov Ya.S., Budza V.G. Sertindol i olanzapin v strukture kompleksnoj terapii bol'nyh shizofreniej s pervym psihoticheskim epizodom: dinamika psihicheskogo sostoyaniya, vliyanie na social'noe funkcionirovanie i pobochnye effekty // Obozrenie psihiatrii i medicinskoj psihologii imeni V.M. Bekhtereva. – 2012. – № 2. –S. 82–93.
  • 8. Antohin E.Yu., Budza V.G., Kryukova E.M., Palaeva R.I. Psihopatologiya depressij na postpristupnom etape techeniya pervogo epizoda shizofrenii: organizaciya pomoshchi pacientam v otdelenii pervogo psihoticheskogo epizoda, ponyatie dissociirovannoj postpristupnoj depressii // Psihiatriya i psihofarmakoterapiya. – 2017. – T. 19, № 4. – S. 4–11.
  • 9. Budza V.G., Antohin E.Yu., Golenishchenko A.V., Kozlov Ya.S., Avelichev V.K. Nekotorye faktory, opredelyayushchie stanovlenie komplaensa v psihiatrii // Psihicheskoe zdorov'e. – 2013. – T. 11. № 9 (88). – S. 26–36.
  • 10. Grigor'eva E.V. Social'noe funkcionirovanie i kachestvo zhizni bol'nyh shizofreniej: fokus na paliperidona pal'mitat (klinicheskij sluchaj) // Obozrenie psihiatrii i medicinskoj psihologii imeni V.M. Bekhtereva. – 2017. – № 1. – S. 59–62.
  • 11. Drobizhev M.Yu., Kalinina E.V., Antohin E.Yu., Sorokina E.Yu. Praktika primeneniya antipsihotikov i korrektorov v psihiatrii. Pervye rezul'taty programmy ANKORPSI (antipsihotiki i korrektory v psihiatrii) // Social'naya i klinicheskaya psihiatriya. – 2015. – T. 25, № 2. – S. 65–77.
  • 12. Cramer J.A., Rosenheck R. Compliance with medication regimens for mental and physical disorders // Psychiatric Serv. – 1998. – No. 49. – P. 196–201.
  • 13. Oehl M., Hummer M., Fleischhacker W. Compliance with antipsychotic treatment // Acta Psychiatr Scand. – 2000. – No. 102. – P. 83–86.
  • 14. Yastrebov D.V. Antipsihoticheskaya terapiya s ispol'zovaniem sovremennyh in"ekcionnyh preparatov dlitel'nogo vyvedeniya. Kliniko-farmakologicheskie rekomendacii po primeneniyu preparata kseplion // RMZh. – 2013. – T. 21. № 30. – S. 1610–1616.
  • 15. Tompsett T., Masters K., Donyai P. The utility of novel outcome measures in a naturalistic evaluation of schizophrenia treatment // Neuropsychiatr Dis Treat. – 2018. – No. 2 (14) – P. 681–691. DOI: 10.2147/NDT.S151174. eCollection 2018. PMID: 29535524
  • 16. Daghistani N., Rey J.A. Invega Trinza: The First Four-Times-a-Year, Long-Acting Injectable Antipsychotic Agent. P T – 2016. – Vol. 41 (4). – P. 222–227.
  • 17. Weiden P.J., Zygmunt A. The road back: working with the severely mentally ill // Medication noncompliance in schizophrenia: part 1. Assessment // J Pract Psychiatry Behav Health. – 1997. – P. 106–110.
  • 18. Biologicheskie metody terapii psihicheskih rasstrojstv (dokazatel'naya medicina – klinicheskoj praktike) / pod red. S.N. Mosolova. – M., 2012.
  • 19. Morozova M.A. Paliperidona pal'mitat (kseplion) v povsednevnoj klinicheskoj praktike v usloviyah psihiatricheskogo stacionara (rezul'taty rossijskoj mnogocentrovoj nablyudatel'noj programmy) // Social'naya i klinicheskaya psihiatriya. – 2014. – T. 24, № 4. – S. 37–40.
  • 20. Bekker R.A., Bykov Yu.V. Prolongirovannye antipsihotiki kompanii «Yanssen» v istoricheskom razreze: proshloe, nastoyashchee, budushchee // Psihiatriya i psihofarmakoterapiya im. P.B. Gannushkina. – 2017. – № 6 – S. 18–27.
  • 21. D'yakov I.N., Zyryanov S.K. Sravnitel'naya ocenka kliniko-ekonomicheskoj effektivnosti primeneniya razlichnyh lekarstvennyh form paliperidona pri lechenii pacientov s shizofreniej // Zhurnal nevrologii i psihiatrii imeni C.C. Korsakova. – 2017. – T. 117, № 2. – S. 85–92.
  • 22. Kolyuckaya E.V., Smulevich A.B. Paliperidona pal'mitat (kseplion) pri podderzhivayushchej terapii bol'nyh shizofreniej: rezul'taty naturalisticheskogo issledovaniya // Zhurnal nevrologii i psihiatrii imeni S.S. Korsakova. – 2013. – T .113, № 11. – S. 50–53
  • 23. Lyubov E.B. Paliperidon pal'mitat – novaya vozmozhnost' farmakoterapii shizofrenii // Social'naya i klinicheskaya psihiatriya. – 2011. – T. 21, № 2. – S. 43–50.
  • 24. Lyubov E.B., Poteshkin N.M., Alekseev S.V., Basenko A.V., Vikina N.A., Iskandyarova R.F., Shinkarenko N.A., Chingaeva I.N., Chapurin S.A., Churilin Yu.Yu. Klinicheskaya i social'naya effektivnost' lecheniya shizofrenii paliperidonom pal'mitatom (kseplion) // Social'naya i klinicheskaya psihiatriya. – 2015. – T. 25, № 1. – S. 59–66.
  • 25. Omel'yanovskij V.V., Avksent'eva M.V., Ivahnenko O.I., Hajlov P.M., Cfasman F.M., Zorin N.A. Ocenka kliniko-ekonomicheskoj effektivnosti lecheniya shizofrenii atipichnymi antipsihotikami prolongirovannogo dejstviya v in"ekcionnoj forme s uchetom priverzhennosti pacientov k terapii // Social'naya i klinicheskaya psihiatriya. – 2012. – T. 22, № 3. – S. 51–60.
  • 26. Petrova N.N., Kucher E.O. Preparaty prolongirovannogo dejstviya v podderzhivayushchej terapii bol'nyh s pervym psihoticheskim epizodom // Social'naya i klinicheskaya psihiatriya. – 2014. – T. 24, № 3. – S. 67–72.
  • 27. Petrova N.N., Ivanov M.V., Kosterin D.N., Serazetdinova V.S., Savel'eva O.V. Harakteristika remissii u bol'nyh shizofreniej na fone lecheniya antipsihoticheskimi preparatami prolongirovannogo dejstviya. // Psihiatriya i psihofarmakoterapiya imeni P.B. Gannushkina. – 2015. – T. 17, № 5–6. – S. 20–25.
  • 28. Emsley R., Kilian S. Efficacy and safety profile of paliperidone palmitate injections in the management of patients with schizophrenia: an evidence-based review // Neuropsychiatr Dis Treat. – 2018. – Jan, No. 5 (14). – P. 205–223. – DOI: 10.2147/NDT.S139633. eCollection 2018. Review. PMID: 29379293
  • 29. Herold R. Long-acting injection – four-times-a-year. Review of the 3-monthly paliperidone-palmitate injection. Article in Hungarian // Psychiatr Hung – 2017. – Vol. 32 (1). – P. 96–107.
  • 30. Nussbaum A.M., Stroup T.S. Paliperidone palmitate for schizophrenia // Cochrane Database Syst Rev. – 2012s. – Art. No.: CD008296. DOI: 10.1002/14651858.CD008296.pub2.
  • 31. Kaplan Gyu, Casey Jyu, Zummo J. Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophrenia // Patient Prefer Adherence. – 2013. – No. 7. – P. 1171–80.
  • 32. Mosolov S.N., Cukarzi E.E., Kapiletti S.G. Antipsihoticheskaya farmakoterapiya shizofrenii: ot nauchnyh dannyh k klinicheskim rekomendaciyam // Mosolov S.N. Biologicheskie metody terapii psihicheskih rasstrojstv. Dokazatel'naya medicina – klinicheskoj praktike. Moskva. – 2012. – S. 11–61.
  • 33. Hasan A., Falkai P., Vobrok T. i dr. Vsemirnaya federaciya obshchestv biologicheskoj psihiatrii: obnovlennaya redakciya 2012 g. po dlitel'noj terapii shizofrenii i taktike vedeniya pacientov s inducirovannymi antipsihoticheskimi preparatami pobochnymi effektami. Ch. 2 // Sovremennaya terapiya psihicheskih rasstrojstv. – 2014. – № 2. – S. 3–36.
  • 34. Mosolov S.N. Osnovy psihofarmakoterapii. M.: Vostok, 1996.
  • 35. Mosolov S.N., Cukarzi E.E. Psihofarmakoterapiya shizofrenii // Psihiatriya: nacional'noe rukovodstvo / pod red. N.G. Neznanova, Yu.A. Aleksandrovskogo. – M., 2018. – S. 299–328.
  • 36. Oleneva E.V., Ryvkin P.V., Ladyzhenskij M.Ya. Vozmozhnosti paliperidona pal'mitata v dlitel'noj protivorecidivnoj terapii shizofrenii (obzor dokazatel'nyh issledovanij) // Sovremennaya terapiya psihicheskih rasstrojstv. – 2018. – № 1. – S. 37–45.
  • 37. Schreiner A. et al. Poster presented at CINP. – 22–26 June 2014. – Vancouver, Canada. Poster LP-01-013.
  • 38. Oleneva E.V., Kapiletti S.G., Ryvkin P.V., Ladyzhenskij M.Ya. Rispolept Konsta – 10 let primeneniya v Rossii: nekotorye itogi // Sovremennaya terapiya psihicheskih rasstrojstv. – 2015. – № 1. – S. 10–24.
  • 39. Pandina G.J., Lindenmayer J.P., Lull J. et al. A randomized, placebo-controlled study to assess the efficacy and safety of 3 doses of paliperidone palmitate in adults with acutely exacerbated schizophrenia // J Clin Psychopharmacol. – 2010. – Vol. 30 (3). – P. 235–244.
  • 40. Avedisova A.S. Ot randomizirovannnyh i observacionnyh issledovanij k ponimaniyu effektivnosti psihofarmakoterapii // Psihiatriya i psihofarmakoterapiya imeni P.B. Gannushkina. – 2009. – № 1. – S. 16–19.
  • 41. Antohin E.Yu., Budza V.G., Kryukova E.M., Harina E.A., Kozlov Ya.S. Affektivnye rasstrojstva bipolyarnogo spektra: osobennosti diagnostiki, podhody k terapii (na primere klinicheskih sluchaev) // Psihicheskoe zdorov'e. – 2014. – T. 12, № 3 (94). – S. 38–56.